Inventor
CLARK DAVID EDWARD
GB23 patents
⚠️ This page may combine multiple inventors who share the name “CLARK DAVID EDWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVENTIS PHARMA LTD
4 patentsUS6479519B1Nov 12, 2002
Substituted anilides
AVENTIS PHARMA LTD72 citations94
US6706738B2Mar 16, 2004
Substituted bicyclic heteroaryl compounds and their use as integrin antagonists
AVENTIS PHARMA LTD20 citations82
US6562851B2May 13, 2003
Substituted bicyclic compounds
AVENTIS PHARMA LTD8 citations72
US6593354B2Jul 15, 2003
Substituted benzoxazole compounds
AVENTIS PHARMA LTD4 citations61
ASTERAND UK LTD
4 patentsUS7803841B2Sep 28, 2010
EP2 receptor agonists
ASTERAND UK LTD11 citations82
US7662839B2Feb 16, 2010
EP2 receptor agonists
ASTERAND UK LTD7 citations72
US7569602B2Aug 4, 2009
Furan derivatives as EP4 receptor antagonists
ASTERAND UK LTD6 citations72
US7417068B2Aug 26, 2008
EP4 receptor antagonists
ASTERAND UK LTD8 citations72
CHIESI FARM SPA
3 patentsUS10954236B2Mar 23, 2021
Tyrosine amide derivatives as Rho-Kinase inhibitors
CHIESI FARM SPA0 citations59
US10501461B2Dec 10, 2019
Tyrosine amide derivatives as Rho-kinase inhibitors
CHIESI FARM SPA0 citations49
US10584128B2Mar 10, 2020
Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitors
CHIESI FARM SPA0 citations40
ANTABIO SAS
3 patentsUS12286411B2Apr 29, 2025
Indane derivatives for use in the treatment of bacterial infection
ANTABIO SAS0 citations57
US12247013B2Mar 11, 2025
Indane derivatives for use in the treatment of bacterial infection
ANTABIO SAS0 citations57
US11000511B2May 11, 2021
Chemical compounds as antibiotics
ANTABIO SAS2 citations57